EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion

Update Il y a 4 ans
Reference: NCT00647192

Woman and Man

Extract

The purpose of this study is to determine whether Eplerenone reduces atrial fibrillation (AF) recurrences within the first 8 weeks after electrical cardioversion of persistent AF.


Inclusion criteria

  • Atrial fibrillation

Links